Market Cap 391.13M
Revenue (ttm) 0.00
Net Income (ttm) -49.77M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 996,100
Avg Vol 993,440
Day's Range N/A - N/A
Shares Out 31.29M
Stochastic %K 34%
Beta 0.52
Analysts Strong Sell
Price Target $50.17

Company Profile

LENZ Therapeutics, Inc. operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, Cal...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 925 7000
Address:
201 Lomas Santa Fe Drive, Suite 300, Solana Beach, United States
Itinerant
Itinerant Mar. 18 at 3:13 PM
$LENZ I watched a YouTube video about cultural attitudes in Japan. One of those attitudes reported was that the Japanese have a very negative attitude about wearing glasses. They think that glasses make one ugly. This suggests that Japan will be a very good market for VIZZ. I do not recall if the LENZ presently has a licensee for Japan.
1 · Reply
NYTWben
NYTWben Mar. 18 at 1:12 PM
$LENZ  I was hoping for more continuation today, but the reversal in the entire market due to war events in the Middle East will probably dampen the follow-through that we were all expecting.
6 · Reply
Itinerant
Itinerant Mar. 17 at 12:38 PM
$LENZ My reading error. Conference call now until the 24th.
0 · Reply
Itinerant
Itinerant Mar. 17 at 12:27 PM
$LENZ Conference call in 4 minutes. Is this normal? Is it good?
0 · Reply
8BALLIAM
8BALLIAM Mar. 17 at 12:01 AM
$LENZ the biggest meh stock out there Shorts, I commend you on the absolute control of this name now go play in traffic
0 · Reply
Itinerant
Itinerant Mar. 16 at 6:39 PM
$LENZ The company is supposed to report on Wednesday. I wonder if the company might report surprising revenues from foreign licensees. I would not expect net profit, but even some revenue from licensees would be exciting. I suppose that I am dreaming.
2 · Reply
NYTWben
NYTWben Mar. 16 at 3:06 PM
$LENZ First Light Asset Management acquired 693,044 shares of LENZ (~$32.28M) in Q3, making LENZ about 3.0% of its portfolio and its 10th-largest holding; First Light now owns 2.21% of the company. ~from market beat.
3 · Reply
Max_Regards
Max_Regards Mar. 16 at 12:23 PM
$LENZ good morning my fellow lovers of volatility. Cheers to a week of beautiful green line going up up up.
0 · Reply
Max_Regards
Max_Regards Mar. 12 at 5:51 PM
$LENZ 4% down today is less of a loss than 4% down from yesterday. Silver linings 😊
2 · Reply
Max_Regards
Max_Regards Mar. 11 at 9:35 PM
$LENZ VIZZ Instagram followers: Feb 4th 2026: 2,249 Followers Feb 15th 2026: 2,390 Followers March 11th 2026 2,846 Followers 26.5% increase from Feb 4th to Mar 11th Feb 4th to Feb 15th: 11.75 followers added per day Feb 15th to Mar 11th: 18.25 followers added per day Total increase and we see an accelerating in crease in the amount of daily followers added. Awareness is definitely ticking up now.
4 · Reply
Latest News on LENZ
LENZ Therapeutics to Present at Upcoming Investor Conferences

Feb 23, 2026, 8:00 AM EST - 24 days ago

LENZ Therapeutics to Present at Upcoming Investor Conferences


LENZ Therapeutics: Was That A Market Overreaction?

Dec 17, 2025, 9:02 AM EST - 3 months ago

LENZ Therapeutics: Was That A Market Overreaction?


LENZ Therapeutics, Inc. (LENZ) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 1:21 PM EST - 4 months ago

LENZ Therapeutics, Inc. (LENZ) Q3 2025 Earnings Call Transcript


LENZ Therapeutics: Undervalued Ahead Of PDUFA

Jul 29, 2025, 1:32 PM EDT - 8 months ago

LENZ Therapeutics: Undervalued Ahead Of PDUFA


LENZ Therapeutics: Presbyopia Eyedrops Look Promising

Jul 1, 2025, 4:23 PM EDT - 9 months ago

LENZ Therapeutics: Presbyopia Eyedrops Look Promising


LENZ Therapeutics, Inc. (LENZ) Q1 2025 Earnings Call Transcript

May 9, 2025, 10:33 AM EDT - 11 months ago

LENZ Therapeutics, Inc. (LENZ) Q1 2025 Earnings Call Transcript


LENZ Therapeutics: Freedom From Reading Glasses

Apr 7, 2025, 8:00 AM EDT - 1 year ago

LENZ Therapeutics: Freedom From Reading Glasses


LENZ Therapeutics Stock Is Attractive Before PDUFA

Mar 27, 2025, 5:33 PM EDT - 1 year ago

LENZ Therapeutics Stock Is Attractive Before PDUFA


LENZ Therapeutics to Host Commercial Day on April 15, 2025

Mar 3, 2025, 8:00 AM EST - 1 year ago

LENZ Therapeutics to Host Commercial Day on April 15, 2025


Lucy Therapeutics Appoints Kim Drapkin as Board Chair

Oct 15, 2024, 8:00 AM EDT - 1 year ago

Lucy Therapeutics Appoints Kim Drapkin as Board Chair

ABOS


LENZ Therapeutics: Upcoming PDUFA, Strong Data, Some Risks

Aug 30, 2024, 8:00 AM EDT - 1 year ago

LENZ Therapeutics: Upcoming PDUFA, Strong Data, Some Risks


Itinerant
Itinerant Mar. 18 at 3:13 PM
$LENZ I watched a YouTube video about cultural attitudes in Japan. One of those attitudes reported was that the Japanese have a very negative attitude about wearing glasses. They think that glasses make one ugly. This suggests that Japan will be a very good market for VIZZ. I do not recall if the LENZ presently has a licensee for Japan.
1 · Reply
NYTWben
NYTWben Mar. 18 at 1:12 PM
$LENZ  I was hoping for more continuation today, but the reversal in the entire market due to war events in the Middle East will probably dampen the follow-through that we were all expecting.
6 · Reply
Itinerant
Itinerant Mar. 17 at 12:38 PM
$LENZ My reading error. Conference call now until the 24th.
0 · Reply
Itinerant
Itinerant Mar. 17 at 12:27 PM
$LENZ Conference call in 4 minutes. Is this normal? Is it good?
0 · Reply
8BALLIAM
8BALLIAM Mar. 17 at 12:01 AM
$LENZ the biggest meh stock out there Shorts, I commend you on the absolute control of this name now go play in traffic
0 · Reply
Itinerant
Itinerant Mar. 16 at 6:39 PM
$LENZ The company is supposed to report on Wednesday. I wonder if the company might report surprising revenues from foreign licensees. I would not expect net profit, but even some revenue from licensees would be exciting. I suppose that I am dreaming.
2 · Reply
NYTWben
NYTWben Mar. 16 at 3:06 PM
$LENZ First Light Asset Management acquired 693,044 shares of LENZ (~$32.28M) in Q3, making LENZ about 3.0% of its portfolio and its 10th-largest holding; First Light now owns 2.21% of the company. ~from market beat.
3 · Reply
Max_Regards
Max_Regards Mar. 16 at 12:23 PM
$LENZ good morning my fellow lovers of volatility. Cheers to a week of beautiful green line going up up up.
0 · Reply
Max_Regards
Max_Regards Mar. 12 at 5:51 PM
$LENZ 4% down today is less of a loss than 4% down from yesterday. Silver linings 😊
2 · Reply
Max_Regards
Max_Regards Mar. 11 at 9:35 PM
$LENZ VIZZ Instagram followers: Feb 4th 2026: 2,249 Followers Feb 15th 2026: 2,390 Followers March 11th 2026 2,846 Followers 26.5% increase from Feb 4th to Mar 11th Feb 4th to Feb 15th: 11.75 followers added per day Feb 15th to Mar 11th: 18.25 followers added per day Total increase and we see an accelerating in crease in the amount of daily followers added. Awareness is definitely ticking up now.
4 · Reply
Max_Regards
Max_Regards Mar. 11 at 9:28 PM
$LENZ remember people, Q4 was prior to the consumer campaign. Q1 of 26 compared to Q4 of 25 will let us see what 1 solid month of increase awareness can do. I hope they tell us some info about sales trends in March as consumer knowledge has definitely seen the bump in March.
2 · Reply
NYTWben
NYTWben Mar. 11 at 5:59 PM
$LENZ $LENZ from Marketbeat: Q4 2025 results are expected to be released before the market opens on Wednesday, March 18, 2026, with analysts forecasting ($0.91) EPS and revenue of about $3.088 million; an earnings call is scheduled for 4:00 PM ET that day.
2 · Reply
Dreamit2
Dreamit2 Mar. 11 at 4:49 PM
$LENZ Shorts are pretty much only interested in companies that have a stable balance sheet. Otherwise they would go after companies like KALA and RGC. No revenues, nothing. There's hundreds of companies like that all across-the-board, but they would rather go after companies with a good solid plan, good solid. Bank accounts and a good solid strategic plan.
0 · Reply
NYTWben
NYTWben Mar. 11 at 2:12 PM
$LENZ Anyone know why Lenz is not releasing press releases for all the recent hedge fund investments? In addition to TYRO's $5M investment in yesterday's filing: Skandinaviska Enskilda Banken AB publ increased its stake in $LENZ 99.0% in the third quarter. They now own 185,642 shares worth $8,647,000 after purchasing an additional 92,362 shares in the 3rd qtr. Sovran Advisors LLC lifted its position in shares of $LENZ 164.5% during the third quarter. They now own 106,920 shares worth $4,980,000 after purchasing an additional 66,497 shares during the last quarter. Versant Venture Management LLC purchased a new stake in shares of $LENZ during the third quarter valued at $123,758,000. Saturn V Capital Management LP purchased a new stake in shares of $LENZ the second quarter valued at $10,033,000. Stempoint Capital LP bought a new position in shares of $LENZ in the second quarter worth $5,390,000. Institutional investors own 54.32% of $LENZ
4 · Reply
philipv777
philipv777 Mar. 10 at 5:20 PM
$LENZ excellent job again at Leerink. I’m very glad they’ve invested in creating a market. Also very glad they’re waiting to partner or license or sell until they’ve proven the market. Can you imagine what they’d get now if they sold after the epic failure that Vuity was? Allergan-esque moves. Love it
3 · Reply
NYTWben
NYTWben Mar. 10 at 5:12 PM
$LENZ Tyro Capital Management LLC Makes New $4.69 Million Investment in LENZ - from today's SEC filings. https://www.marketbeat.com/instant-alerts/filing-tyro-capital-management-llc-makes-new-469-million-investment-in-lenz-therapeutics-inc-lenz-2026-03-10/
2 · Reply
NYTWben
NYTWben Mar. 10 at 2:29 PM
$LENZ Listening to the Leerink fireside chat now. The CEOis literally talking about the business plan right now. Nod to short here NICO who always says no business plan. He is comparing the phased launch to $TARS (I also own TARSUS). $TARS is a doing great.
3 · Reply
NYTWben
NYTWben Mar. 10 at 1:42 PM
$LENZ $LENZ Lenz has submitted for their regulatory approval for sales in the Europe Union. This will take a while to get approved but it’s a good. To summarize they are expecting similar approval for Greater China (relatively soon), South Korea, Canada, Saudi Arabia and UAE.
0 · Reply
Max_Regards
Max_Regards Mar. 9 at 8:43 PM
$LENZ interesting… FDA FAERS data base is showing only 1 report in Feb and zero so far in March. Odd considering there were 167 events in Dec and 146 in Jan… FDA FAERS is an unaudited anonymous system as well and subject to false claims. The shorts were ABSOLUTELY submitting false claims to stir the pot. Wild. No way a drug goes from 150 cases avg for two months to virtually 0 unless if the drug was pulled from the market. (This is a baseless accusation with no facts to back it up other than the data here makes ZERO sense)
7 · Reply
philipv777
philipv777 Mar. 9 at 1:32 PM
$LENZ Leerink tomorrow at 10am https://ir.lenz-tx.com/news-events/press-releases/detail/49/lenz-therapeutics-to-present-at-upcoming-investor-conferences
1 · Reply
NYTWben
NYTWben Mar. 7 at 9:09 PM
$LENZ this is purely anecdotal, but apparently Vizz is on backwater here in South Florida. 
5 · Reply
SirRahal
SirRahal Mar. 6 at 7:51 PM
$LENZ Choppy down here.... might see a bounce. Could this be a double bottom? This call is a little harder b/c the trend in the market is dark red... But, I'm looking for an uptrend and buying in.
2 · Reply